文献速递心力衰竭与心肌病

应激性(Takotsubo)心肌病后持续存在的长期结构、功能与代谢改变

Persistent Long-Term Structural, Functional, and Metabolic Changes After Stress-Induced (Takotsubo) Cardiomyopathy.
PubMed 文献 · Circulation · 2017-11-11

该观察性病例对照研究纳入37例既往超过12个月的Takotsubo心肌病患者和37例年龄、性别及合并症匹配的对照。尽管左心室射血分数和血清生物标志物正常,患者仍存在心衰症状、运动能力下降、心肌形变受损、native T1升高及心脏能量代谢障碍,提示Takotsubo心肌病遗留长期心衰表型。

要点

  • Takotsubo心肌病后多数患者持续存在心衰症状和运动耐量下降。
  • 即使射血分数正常,仍可见心肌形变、T1 mapping及能量代谢异常。
  • 应将该病视为具有长期心衰表型的疾病,而非完全自限。

核心结论

  • Takotsubo心肌病具有长期临床后果,包括症状和功能受损,并与持续亚临床心功能障碍相关。
  • 患者在该病后形成持续长期的心衰表型。

研究设计与样本

  • 观察性病例对照研究,纳入37例既往超过12个月的Takotsubo心肌病患者和37例年龄、性别及合并症匹配的对照。
  • 所有参与者接受血清生物标志物分析、心肺运动试验、超声心动图和心脏磁共振(含31P波谱)等详细临床表型分析。

主要发现

  • 患者多数(88%)持续存在符合心衰的症状,明尼苏达心衰生活质量问卷中位评分为13(范围0-76)。
  • 运动试验显示峰值耗氧量降低(24±1.3 vs 31±1.3 mL/kg/min,P<0.001),VE/Vco2斜率升高(31±1 vs 26±1,P=0.002)。
  • 尽管左心室射血分数和血清生物标志物正常,患者心尖部周向应变减低(-16±1.0 vs -23±1.5%,P<0.001),整体纵向应变减低(-17±1 vs -20±1%,P=0.006)。
  • native T1 mapping值升高(1264±10 vs 1184±10 ms,P<0.001),心脏能量状态受损(磷酸肌酸/γ-三磷酸腺苷比值1.3±0.1 vs 1.9±0.1,P<0.001)。

临床怎么用

  • 对Takotsubo心肌病后患者应长期随访心衰症状和运动耐量,不应因射血分数恢复而认为完全康复。
  • 可考虑心肺运动试验和心脏磁共振(含T1 mapping及31P波谱)评估亚临床心功能障碍。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Takotsubo cardiomyopathy is an increasingly recognized acute heart failure syndrome precipitated by intense emotional stress. Although there is an apparent rapid and spontaneous recovery of left ventricular ejection fraction, the long-term clinical and functional consequences of takotsubo cardiomyopathy are ill-defined. METHODS: In an observational case-control study, we recruited 37 patients with prior (>12-month) takotsubo cardiomyopathy, and 37 age-, sex-, and comorbidity-matched control subjects. Patients completed the Minnesota Living with Heart Failure Questionnaire. All participants underwent detailed clinical phenotypic characterization, including serum biomarker analysis, cardiopulmonary exercise testing, echocardiography, and cardiac magnetic resonance including cardiac 31P-spectroscopy. RESULTS: Participants were predominantly middle-age (64±11 years) women (97%). Although takotsubo cardiomyopathy occurred 20 (range 13-39) months before the study, the majority (88%) of patients had persisting symptoms compatible with heart failure (median of 13 [range 0-76] in the Minnesota Living with Heart Failure Questionnaire) and cardiac limitation on exercise testing (reduced peak oxygen consumption, 24±1.3 versus 31±1.3 mL/kg/min, P<0.001; increased VE/Vco2 slope, 31±1 versus 26±1, P=0.002). Despite normal left ventricular ejection fraction and serum biomarkers, patients with prior takotsubo cardiomyopathy had impaired cardiac deformation indices (reduced apical circumferential strain, -16±1.0 versus -23±1.5%, P<0.001; global longitudinal strain, -17±1 versus -20±1%, P=0.006), increased native T1 mapping values (1264±10 versus 1184±10 ms, P<0.001), and impaired cardiac energetic status (phosphocreatine/γ-adenosine triphosphate ratio, 1.3±0.1 versus 1.9±0.1, P<0.001). CONCLUSIONS: In contrast to previous perceptions, takotsubo cardiomyopathy has long-lasting clinical consequences, including demonstrable symptomatic and functional impairment associated with persistent subclinical cardiac dysfunction. Taken together our findings demonstrate that after takotsubo cardiomyopathy, patients develop a persistent, long-term heart failure phenotype. CLINICAL TRIAL REGISTRATION: URL: https://clinicaltrials.gov. Unique identifier: NCT02989454.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Scally C, Rudd A, Mezincescu A, et al. Persistent Long-Term Structural, Functional, and Metabolic Changes After Stress-Induced (Takotsubo) Cardiomyopathy. Circulation. 2017. PMID: 29128863. doi:10.1161/CIRCULATIONAHA.117.031841

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。